Long before psilocybin mushrooms showed up in clinical trials or ballot initiatives, they were already woven into the fabric of human culture. Thousands of years of ceremonial use, a mid-century rediscovery, decades of prohibition, and now a full-blown research renaissance — the history here is genuinely remarkable. Knowing it makes everything happening today feel a lot less sudden.
Ancient roots in Mesoamerica
The richest historical record comes from Indigenous cultures in what’s now Mexico and Central America. Archaeological finds — including stone sculptures from Guatemala that appear to depict stylized mushrooms — suggest ceremonial use stretching back over 2,000 years.
The Mazatec, Mixtec, Aztec, and Zapotec peoples all had relationships with these fungi. For the Aztecs, psilocybin mushrooms were called teonanácatl — roughly translated as “flesh of the gods” — and were used in religious ceremonies to induce visions and commune with the divine.
Spanish colonizers in the 16th century documented these practices, even as they worked to stamp them out. Franciscan friar Bernardino de Sahagún recorded in The Florentine Codex that people consumed mushrooms during ceremonies that brought on visions and altered states. The colonial project tried hard to erase these traditions — but it didn’t fully succeed.
The knowledge that survived
Among the Mazatec people of Oaxaca, the ceremonial use of sacred mushrooms quietly continued through the centuries, carried by traditional healers called curanderos and curanderas. These weren’t recreational users — they were practitioners working within a sophisticated spiritual and healing framework.
The figure who would eventually bridge that world and the Western one was María Sabina, a Mazatec healer who conducted mushroom ceremonies for her community and, later, for outside researchers. Her openness — and the complicated legacy that followed — changed the trajectory of how the West came to understand these substances.
The moment everything changed: the 1950s
In 1955, an amateur ethnomycologist named R. Gordon Wasson traveled to Oaxaca and sat in ceremony with María Sabina. Two years later, he wrote about the experience in Life magazine under the title “Seeking the Magic Mushroom.” Millions of people read it. The curiosity it ignited was immediate and enormous.
That article is often treated as the moment psilocybin entered the Western imagination — and the ripple effects were fast.
Swiss chemist Albert Hofmann — the same person who discovered LSD — read the work coming out of Oaxaca and got to work. By 1958, he had isolated the active compounds: psilocybin and psilocin. The pharmaceutical company Sandoz eventually distributed synthetic psilocybin to researchers under the name Indocybin, opening the door to clinical study.
A decade of research, then a hard stop
Through the late 1950s and into the 1960s, researchers explored psilocybin as a possible treatment for depression, alcoholism, end-of-life anxiety, and more. One of the most famous studies from this era — the 1962 Marsh Chapel Experiment at Harvard — found that participants who received psilocybin during a religious service overwhelmingly reported profound mystical experiences. The implications felt significant.
But the cultural and political climate was shifting. Psychedelics became tangled up with the counterculture, and governments moved decisively. In 1970, the U.S. Controlled Substances Act placed psilocybin in Schedule I — the most restrictive category, reserved for substances deemed to have high abuse potential and no accepted medical use. Research essentially stopped overnight.
The long pause, and what came after
For roughly three decades, psilocybin research was almost nonexistent. Then, quietly, it started coming back.
In the early 2000s, institutions like Johns Hopkins, Imperial College London, and NYU Langone began publishing new studies. The results were striking — suggesting real promise for treatment-resistant depression, PTSD, substance use disorders, and end-of-life distress. This time, the research came with careful protocols: structured preparation, guided sessions, and deliberate integration work afterward.
The cultural shift followed the science. Oregon created a regulated psilocybin services program in 2020. Colorado voted to legalize natural medicine access in 2022. Cities across the country began decriminalizing psychedelic plants and fungi. Federal law hasn’t moved — but the ground around it certainly has.
Where this leaves us
The arc of this story — ancient ritual, colonial suppression, Western rediscovery, scientific enthusiasm, political prohibition, and now cautious renaissance — is unlike almost anything else in the history of medicine or culture.
What’s interesting now is that modern research isn’t just rediscovering psilocybin from scratch. In many ways, it’s catching up to what Indigenous healers understood for centuries. The conversation happening today is, at its core, a very old one.